American Journal of Epidemiology Vol. 93, No. 5: 384-391
Copyright © 1971 by The Johns Hopkins University School of Hygiene and Public Health
other |
FIELD EVALUATION OF COMBINED MORE ATTENUATED LIVE MEASLES (MORATEN)-SMALLPOX VACCINE IN HONDURAS AND COSTA RICA1
2Reprint requests to Dr. Hilleman, Division of Virus and Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pennsylvania 19486.
Villarejos, V. M., A. Rodríguez-Aragonés, N. Gúnera, J. A. Arguedas G., E. B. Buynak and M. R. Hilleman (Merck Institute for Therapeutic Research, West Point, Pa. 19486). Field evaluation of combined more attenuated live measles (Mora-ten)-smallpox vaccine in Honduras and Costa Rica. Amer J Epidem 93: 384391, 1971.Four lots of premixed and lyophilized preparations of Moraten line Enders' live measles virus vaccine combined with calf lymph smallpox vaccine were evaluated in clinical studies carried out among children in Costa Rica and Honduras. Careful study was made of 354 children who were initially seronega-tive for both viruses and 560 children who bore a previous vaccination scar. Additionally, 1096 children who gave a negative history for measles and smallpox were given vaccine but observed only for evolution of the dermal lesion and for clinical reaction. The combined vaccine was highly effective in eliciting antibodies against both viruses in initially seronegative children. All children developed local lesions to the vaccinia component and nearly all gave immune or vaccinoid reactions on subsequent challenge with smallpox vaccine by multiple puncture. Further, the bivalent vaccine was adequate to elicit dermal reactions In nearly all persons with a previous smallpox vaccination scar. The febrile responses to combined vaccine were no greater than expected for either vaccine given alone. It was concluded that the Moraten measles and smallpox vaccine in combined form can be safely and effectively administered via jet gun with considerable savings in time and with minimal discomfort.
measles vaccine; smallpox vaccine; vaccines; evaluation
1From the Louisiana State University International Center for Medical Research and Training, San Jose, Costa Rica; and the Division of Virus and Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pennsylvania.